Skip to main content
. 2023 Aug 17;14(5):2301–2309. doi: 10.1002/jcsm.13315

Figure 4.

Figure 4

Depiction of the receiver operating characteristic (ROC) curve for Subgroup 1, that is, patients who underwent sorafenib monotherapy. AUC, area under the curve.